106 related articles for article (PubMed ID: 2850449)
21. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
22. Retrieval of latent herpes simplex virus type 1 genetic information from murine trigeminal ganglia by superinfection with heterotypic virus in vivo.
Thomas E; Lycke E; Vahlne A
J Gen Virol; 1985 Aug; 66 ( Pt 8)():1763-70. PubMed ID: 2991439
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL
J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091
[TBL] [Abstract][Full Text] [Related]
24. Typing of herpes simplex virus with synthetic DNA probes.
Peterson EM; Aarnaes SL; Bryan RN; Ruth JL; de la Maza LM
J Infect Dis; 1986 Apr; 153(4):757-62. PubMed ID: 3005436
[TBL] [Abstract][Full Text] [Related]
25. Persistence of herpes simplex virus type 1 in rat neurotumor cells.
Doller E; Aucker J; Weissbach A
J Virol; 1979 Jan; 29(1):43-50. PubMed ID: 219234
[TBL] [Abstract][Full Text] [Related]
26. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
27. Amplification of herpes simplex virus resistance in mouse neuroblastoma (Cl300) cells.
Nilheden E; Jeansson S; Vahlne A
Arch Virol; 1985; 83(3-4):269-83. PubMed ID: 2578786
[TBL] [Abstract][Full Text] [Related]
28. Persistent infection with herpes simplex virus type 1 in an Ia antigen-positive murine macrophage cell line.
Tang JL; Yamamoto M; Sakuma S; Mori R; Nagayama A
Microbiol Immunol; 1988; 32(4):363-74. PubMed ID: 2839754
[TBL] [Abstract][Full Text] [Related]
29. Herpes simplex virus type 2 infection of unstimulated human T-lymphocytes.
Kucera LS; Raben D; Iyer N; Ricardo MJ
Viral Immunol; 1989; 2(1):11-6. PubMed ID: 2545223
[TBL] [Abstract][Full Text] [Related]
30. Butyrate-induced reversal of herpes simplex virus restriction in neuroblastoma cells.
Ash RJ
Virology; 1986 Dec; 155(2):584-92. PubMed ID: 3024402
[TBL] [Abstract][Full Text] [Related]
31. H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication.
Botting C; Lu X; Triezenberg SJ
Virol J; 2016 Jan; 13():15. PubMed ID: 26817608
[TBL] [Abstract][Full Text] [Related]
32. Thymidine kinase deficient human cells have increased UV sensitivity in their capacity to support herpes simplex virus but normal UV sensitivity for colony formation.
Rainbow AJ
Mutat Res; 1989 Nov; 218(3):189-96. PubMed ID: 2554138
[TBL] [Abstract][Full Text] [Related]
33. Transformation of cells by herpes simplex virus--fact or fantasy?
McAuslan BR; Garfinkle B; Adler R; Devinney D; Florkiewicz R; Shaw JE
Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():765-72. PubMed ID: 169030
[TBL] [Abstract][Full Text] [Related]
34. Activation of herpes simplex virus (HSV) type 1 genome by temperature-sensitive mutants of HSV type 2.
Wigdahl BL; Isom HC; De Clercq E; Rapp F
Virology; 1982 Jan; 116(2):468-79. PubMed ID: 6278723
[TBL] [Abstract][Full Text] [Related]
35. Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction.
Adler R; Glorioso JC; Levine M
J Gen Virol; 1978 Apr; 39(1):9-20. PubMed ID: 205630
[TBL] [Abstract][Full Text] [Related]
36. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
[TBL] [Abstract][Full Text] [Related]
37. Analysis of viral proteins in human cytomegalovirus-infected cells during impaired lytic replication of herpes simplex virus.
Cockley KD; Rapp F
Virology; 1989 May; 170(1):268-72. PubMed ID: 2541541
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus.
Colberg-Poley AM; Isom HC; Rapp F
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5948-51. PubMed ID: 230494
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of herpes simplex virus replication and protein synthesis by non-smoked tobacco, tobacco alkaloids and nitrosamines.
Larsson PA; Hirsch JM; Gronowitz JS; Vahlne A
Arch Oral Biol; 1992 Nov; 37(11):969-78. PubMed ID: 1334651
[TBL] [Abstract][Full Text] [Related]
40. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
